Preclinical • Combination therapy • Checkpoint inhibition • PARP Biomarker • PD(L)-1 Biomarker • IO biomarker • Checkpoint block
|
HRD (Homologous Recombination Deficiency) • VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1)
|
VTCN1 underexpression
|
AZD8205 • saruparib (AZD5305)